Clinical Trial Update: To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of netakimab in Chinese patients with moderate to severe plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Netakimab (netakimab)

Snippet

Sponsor: SPH-BIOCAD (HK) Limited | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED